| TTM
|
12/31/2025
|
12/31/2024
|
12/31/2023
|
12/31/2022
|
|
|---|---|---|---|---|---|
| Total Revenue
|
86,462,000 | 65,179,000 | 45,043,000 | 34,124,000 | 28,541,400 |
|
Cost of Revenue
|
-14,150,000 | -11,052,000 | -8,418,000 | -7,082,000 | -6,629,800 |
|
Gross Profit
|
72,312,000 | 54,127,000 | 36,625,000 | 27,042,000 | 21,911,600 |
|
Selling, General and Administrative Expenses
|
-12,620,000 | -11,094,000 | -8,594,000 | -7,404,000 | -6,440,400 |
|
Research and Development Expenses
|
-15,377,000 | -13,337,000 | -10,991,000 | -9,313,000 | -7,190,800 |
|
Operating Income/Expenses
|
-27,997,000 | -24,431,000 | -19,585,000 | -16,717,000 | -13,631,200 |
|
Total Operating Profit/Loss
|
44,315,000 | 29,696,000 | 17,040,000 | 10,325,000 | 8,280,400 |
| Total Net Finance Income/Expense
|
-699,500 | -- | -605,400 | -312,300 | -268,800 |
| Net Investment Income
|
-5,900 | -- | -49,500 | -20,200 | -410,700 |
| Irregular Income/Expenses
|
-9,439,000 | -3,394,000 | -4,141,000 | -3,868,000 | -1,153,100 |
|
Other Income/Expense, Non-Operating
|
-107,000 | -571,000 | -219,000 | 97,000 | 358,600 |
|
Non-Operating Income/Expenses, Total
|
-9,546,000 | -3,965,000 | -4,360,000 | -3,771,000 | -1,474,000 |
|
Pretax Income
|
34,769,000 | 25,731,000 | 12,680,000 | 6,554,000 | 6,806,400 |
|
Provision for Income Tax
|
-7,189,000 | -5,091,000 | -2,090,000 | -1,314,000 | -561,600 |
|
Net Income from Continuing Operations
|
27,580,000 | 20,640,000 | 10,590,000 | 5,240,000 | 6,244,800 |
|
Net Income after Extraordinary Items and Discontinued Operations
|
27,580,000 | 20,640,000 | 10,590,000 | 5,240,000 | 6,244,800 |
|
Net Income after Non-Controlling/Minority Interests
|
27,580,000 | 20,640,000 | 10,590,000 | 5,240,000 | 6,244,800 |
|
Net Income Available to Common Stockholders
|
27,580,000 | 20,640,000 | 10,590,000 | 5,240,000 | 6,244,800 |
|
Diluted Net Income Available to Common Stockholders
|
27,580,000 | 20,640,000 | 10,590,000 | 5,240,000 | 6,244,800 |
|
Common Dividend per Share
|
6.69 | 6.23 | 5.40 | 4.69 | 4.07 |
| Basic EPS
|
30.85 | 23.00 | 11.76 | 5.82 | 6.93 |
| Diluted EPS
|
30.81 | 22.95 | 11.71 | 5.80 | 6.90 |
|
Basic Weighted Average Shares Outstanding
|
893,625 | 897,300 | 900,600 | 900,200 | 901,736 |
|
Diluted Weighted Average Shares Outstanding
|
895,325 | 899,300 | 904,100 | 903,300 | 904,619 |
|
Reported Normalized Diluted EPS
|
31.95 | 24.21 | 12.99 | 6.32 | 7.94 |
| Income Statement, Supplemental
|
|||||
|
EBIT
|
35,824,000 | 25,731,000 | 12,680,000 | 6,554,000 | 7,075,200 |
|
EBITDA
|
37,998,000 | 27,728,000 | 14,447,000 | 8,081,000 | 8,597,700 |
|
Normalized EBITDA
|
48,135,000 | 31,568,000 | 19,010,000 | 10,699,000 | 10,376,100 |
|
Normalized Income
|
28,606,000 | 21,768,000 | 11,746,500 | 7,331,782 | 7,186,400 |
12/31/2022 - 1/3/2000
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade